CMPX

Conviction 24HealthcareScan · Thu, Jun 25, 2026

Bullish engulfing

CMPX$2.07+2.23%

ResistanceSupportVol 14

Vol MA14 3.82M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Compass Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.compasstherapeutics.com ↗

Price2.07

Change+2.23%

Gap-0.25%

Rel volume2.27×

Avg volume4.16M

Avg $ vol8.75M

SMA 202.09

SMA 502.57

SMA 2004.41

Price vs 50-19.50%

Price vs 200-53.13%

MA stackbearish

50/200 cross—

Supertrenddown · 2.43

RSI (14)44

MACD hist0.05

MACD cross—

Stoch %K / %D71 / 60

ADX (14)21

+DI / −DI18 / 24

RSI divergence—

MACD divergence—

ATR %+7.20%

ADR %5.55%

52w high6.69

52w low1.67

From 52w high-69.13%

Above 52w low+23.65%

New 52w highNo

SqueezeOn · 6d

Bollinger width22.77%

%B0.46

Donchian pos31.36%

Donchian high2.47

Donchian low1.88

AVWAP (52w high)2.83

vs AVWAP high-27.12%

AVWAP (52w low)1.96

vs AVWAP low+5.42%

OBV trendFlat

Chaikin MF (20)-0.16

Today vs 20d2.27×

Avg vol (14d)3.82M

Avg vol (20d)4.16M

Avg $ vol (20d)8.75M

Market cap371.88M

RS 3m (vs SPY)-74.36%

RS 6m (vs SPY)-67.25%

RS line new highNo

Trend template1/8

Technical rank9.9

1 week+0.73%

1 month-6.14%

3 months-62.39%

6 months-59.82%

1 year-21.18%

YTD-60.06%

P/E-5.59

P/B1.99

P/S—

P/FCF-7.56

EPS-1.31

Div yield—

ROE-35.66%

ROA-32.41%

Debt/Eq0.00

Current19.04

EV/EBITDA-4.38

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-34.66%

Price target9.38

Target upside354.24%

Analyst ratingBuy

Institutional100.89%

Ent. value316.71M

Revenue0

Net income-18.32M

Gross profit—

Free cash flow-49.17M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out180.09M

Employees39

ListedFri, Nov 13, 2020

Free float96.72M

Float %54.4%

Short interest33.27M

Days to cover6.4d

Short volume32.6%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.10 vs −$0.10

Last surprise0.0% beat

Setup gradeD

Conviction24 / 100

Pattern quality—

Tech rank9.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CMPX

All disclosures →

No recent disclosed trades by Congress in CMPX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CMPX · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Anderman Jonathan General Counsel · Common Stock · 2026-04-29	Grant	25K	$47K	2026-04-29	2026-04-29
Lerner Neil Chief Accounting Officer · Common Stock · 2026-04-29	Grant	15K	$28K	2026-04-29	2026-04-29

SEC filings

EDGAR filings in CMPX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.